by Sue Robbins | Jun 3, 2020 | Migraine
There’s no mistaking a migraine headache — the excruciating head pain, nausea and sensitivity to light and sound. The incapacitating attacks can last for hours or days and are sometimes frequent enough to cause moderate or severe disability. “Fortunately, the list of...
by Sue Robbins | Jun 1, 2020 | Migraine
Between 1997 and 2012, the inpatient burden of migraine cost rapidly increased in the United States, according to a study published in Plastic and Reconstructive Surgery-Global Open. Migraine affects nearly 1 in 7 Americans every year and tends to affect women more...
by Sue Robbins | May 27, 2020 | Migraine
Surgical decompression of supraorbital and supratrochlear nerves may aid migraineurs experiencing moderate to severe chronic frontal migraine who do not respond to medications, according to a study published in Plastic and Reconstructive Surgery (PRS) Global Open....
by Sue Robbins | May 22, 2020 | Migraine
Insufficient response to triptans is associated with poor health-related quality of life (HRQoL) and lower work productivity in migraineurs compared with those who respond well to the medications, according to a study published in The Journal of Headache and Pain....
by Sue Robbins | May 18, 2020 | Migraine
The FDA has approved Dr. Reddy’s Laboratories’ celecoxib oral solution (Elyxyb) for the treatment of acute migraine in adults with or without aura. Notably, the non-steroidal anti-inflammatory drug (NSAID) was given the go-ahead with a boxed warning related to a risk...
